Distinguished in Cholangiocarcinoma (Bile Duct Cancer)

Shunsuke Kondo

Tokyo, JP 
Distinguished in Cholangiocarcinoma (Bile Duct Cancer)
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Shunsuke Kondo practices in Tokyo, Japan. Mr. Kondo is rated as a Distinguished expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Ampullary Cancer, Endoscopy, and Pancreaticoduodenectomy.

His clinical research consists of co-authoring 152 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Cholangiocarcinoma (Bile Duct Cancer).

Gender
Male

Locations

Tokyo, Japan
Other Locations
Chuo, Japan
Chuo, Japan
Japan
Mishima, Japan
Bunkyo, Japan
Shinjuku, 1628480, Japan
Fukuoka, Japan
Nagoya, Japan
Minato, Japan
Osaka, Japan
Tsukiji, 1040045, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1 Study of LY3200882 in Patients With Solid Tumors
A Phase 1 Study of LY3200882 in Patients With Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug, Radiation
Study Phase: Phase 1

152 Total Publications

Final Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.
Final Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kondo's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile